Recruitment

Recruitment Status
Completed

Inclusion Criterias

Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.
Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.

Exclusion Criterias

All subjects are excluded unless previously participating in studies B1871006 or B1871008.
All subjects are excluded unless previously participating in studies B1871006 or B1871008.

Summary

Conditions
Chronic Myeloid Leukemia
Type
Interventional
Design
Masking: None (Open Label)

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.
Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.

Exclusion Criterias

All subjects are excluded unless previously participating in studies B1871006 or B1871008.
All subjects are excluded unless previously participating in studies B1871006 or B1871008.

Locations

Saint Petersburg, 197341
Atlanta, Georgia, 30322
Sandy Springs, Georgia, 30342
Gdańsk, 80-952
Toledo, 45004
...
Saint Petersburg, 197341
Atlanta, Georgia, 30322
Sandy Springs, Georgia, 30342
Gdańsk, 80-952
Toledo, 45004
Orbassano, TO, 10043
Vellore, Tamil NADU, 632004
Barcelona, 08036
Hershey, Pennsylvania, 17033-0850
Tokyo, 113-8677
Akita City, Akita, 010-8543
Renaca, V Region, 2540488
Madrid, 28050
Kyiv, 04112
Groningen, 9713 GZ
Budapest, 1097
Saint Petersburg, 197022
Cherkasy, 18009
Cd. Autonoma De Buenos Aires, Buenos Aires, C1426ANZ
Rostov-on-Don, 344022
Dnipropetrovsk, 49102
Helsinki, 00290
Gaziantep, Sehit Kamil, 27310
Ankara, 06100
Roma, 00144
Moscow, 125167
Nantes cedex 1, 44093
Kyiv, 03115
Atlanta, Georgia, 30322
La Plata, Buenos Aires, 1900
Kaposvar, 7400
Renaca, V Region, 2540364
Vancouver, British Columbia, V5Z1M9
Beijing, 100853
Helsinki, 00290
Kyiv, 04112
Nottinhgam, NG5 1PB
Monza, Monza AND Brianza, 20090
Suita-city, Osaka, 565-0871
Adelaide, South Australia, 5000
Shatin, New Territories
Gdansk, 80-214
Bethesda, Maryland, 20817
Madrid, 28046
Bethesda, Maryland, 20817
Houston, Texas, 77030
Atlanta, Georgia, 30342
Lviv, 79044
Amsterdam, 1081 HV
Montreal, Quebec, H3T 1E2
Chai Wan
Bogota, Cundinamarca, 110111
Helsinki, 00290
Orlando, Florida, 32806
Poitiers Cedex, 86021
Ekaterinburg, Sverdlovsk Region, 620102
Tianjin, 300020
Beijing, Beijing, 100730
Vellore, Tamil Nadu, 632 004
Rostov-on-Don, Rostov Region, 344015
Seoul, 06591
Herston, Queensland, 4029
Strasbourg, 67000
Osakasayama-city, Osaka, 589-8511
Kanazawa-shi, Ishikawa, 920-8641
Poitiers, 86021
Renaca, V Region, 2540488
Caen Cedex 9, 14033
Valencia, 46010
Toronto, Ontario, M5G 2M9
Helsinki, 00290
Soweto, Gauteng, 2013
Strasbourg, 67000
Bangkok, 10700
Herston, Queensland, 4029
Shanghai, 200025
Hangzhou, Zhejiang, 310003
Newcastle Upon Tyne, UK, NE7 7DN
Houston, Texas, 77030
Suita-city, Osaka, 565-0871
Hawthorne, New York, 10532
Riga, LV-1079
Hamamatsu-shi, Shizuoka, 431-3192
Edmonton, Alberta, T6G 1Z2
Indianapolis, Indiana, 46237
Charleroi, 6000
Fukuoka-shi, Fukuoka, 811-1395
Samara, 443095
Lublin, 20-081
Atlanta, Georgia, 30322
Indianapolis, Indiana, 46237
Bologna, BO, 40138
Singapore, 169608
Saint Petersburg, 194291
Orlando, Florida, 32806
Toyohashi, Aichi, 4418570
Corrientes,, 3400
Madrid, 28006
Lima, 11
Bogota, Cundinamarca, 110111
Shatin, New Territories
Barcelona, 08036
Houston, Texas, 77030
Campinas, SP, 13083-878
Krakow, 31-501
Santo Andre, SP, 09060-650
Sioux City, Iowa, 51101

Tracking Information

NCT #
NCT01903733
Collaborators
Not Provided
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer